Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials

Dengue is prevalent in the Asia-Pacific region. Participants of two immunogenicity and safety phase II studies conducted in Singapore and Vietnam (NCT0088089 and NCT00875524, respectively) were followed for up to four years after third vaccine dose of a recombinant, live, attenuated, tetravalent den...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: Tran, Ngoc Huu, Chansinghakul, Danaya, Chong, Chia Yin, Low, Chian Yong, Shek, Lynette P., Luong, Chan Quang, Fargo, Carina, Wartel, T. Anh, Sun, Sunny, Skipetrova, Anna, Bouckenooghe, Alain
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2019
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816352/
https://ncbi.nlm.nih.gov/pubmed/30724660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1578595
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia